Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene vaccines

B Wahren1

  • 1Microbiology and Tumorbiology Center, Swedish Institute for Infectious Disease Control, Karolinska Institute, Stockholm, Sweden.

Immunotechnology : an International Journal of Immunological Engineering
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity.

Scientific reports·2018
Same author

HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV.

Heliyon·2017
Same author

Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses.

Human vaccines & immunotherapeutics·2017
Same author

The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children.

Journal of virus eradication·2016
Same author

Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial.

Vaccine·2011
Same author

Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin.

Vaccine·2008
Same journal

Complementarity-determining region (CDR) implantation: a theme of recombination.

Immunotechnology : an international journal of immunological engineering·1999
Same journal

Recombinant antibodies with the antigen-specific, MHC restricted specificity of T cells: novel reagents for basic and clinical investigations and immunotherapy.

Immunotechnology : an international journal of immunological engineering·1999
Same journal

Sequence-specific antibodies against human IgE isoforms induced by an epitope display system.

Immunotechnology : an international journal of immunological engineering·1999
Same journal

Properties and pharmacokinetics of two humanized antibodies specific for L-selectin.

Immunotechnology : an international journal of immunological engineering·1999
Same journal

An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G protein.

Immunotechnology : an international journal of immunological engineering·1999
Same journal

An scFv phage clone that binds to human beta2-microglobulin.

Immunotechnology : an international journal of immunological engineering·1999
See all related articles

Naked DNA efficiently expresses genes in animal tissues, persisting as episomes. This DNA vaccine technology offers safe, long-term immune responses comparable to live vaccines, revolutionizing human vaccine development.

Area of Science:

  • Molecular Biology
  • Immunology
  • Vaccinology

Background:

  • Naked DNA, when introduced into animal tissues, is efficiently taken up and expressed by cells.
  • Plasmids containing promoters and enhancers facilitate DNA expression.
  • Expressed DNA persists as extrachromosomal nuclear episomes, not integrating into chromosomal DNA.

Purpose of the Study:

  • To investigate the efficiency and immune response generated by DNA vaccines.
  • To explore the potential of DNA vaccines for human applications.

Main Methods:

  • Injection of plasmid DNA into animal tissues.
  • Observation of DNA uptake, expression, and persistence within cells.
  • Analysis of induced immune responses (humoral and cellular).

Related Experiment Videos

Main Results:

  • Efficient gene expression from injected DNA in somatic cells.
  • In vivo expression of DNA and RNA following injection.
  • Induction of immunogenic proteins and robust immune responses.
  • Long-term humoral and cellular immunity generated, similar to live attenuated vaccines.

Conclusions:

  • DNA vaccines provide a safe alternative to live infectious agents.
  • These vaccines elicit potent and durable immune responses.
  • The findings have significant implications for developing novel human vaccines.